Results 291 to 300 of about 358,941 (349)

Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinic. [PDF]

Cancer
Nassif Haddad E, Javle MM, Yap TA.
europepmc   +1 more source

Protein Phosphatase 1 Regulatory Subunit 3C integrates cholesterol metabolism and isocitrate dehydrogenase in chondrocytes and neoplasia. [PDF]

Proc Natl Acad Sci U S A
Nakagawa M, Shimada E, Guardino N, Miyamoto R, Puviindran V, Peairs E, Matarangas A, Ishikawa K, Nguyen T, Browne M, Marius C, Wallace A, Hirata M, Nadesan P, Alman BA.   +14 more
europepmc   +1 more source

Correlation between Isocitrate Dehydrogenase Mutation and Immunohistochemical Expression of DNA Mismatch Repair Proteins in the Prognosis of Gliomas. [PDF]

Asian Pac J Cancer Prev
Saeed NM, Rashed H, Hussein S, Al-Karamany AS, Elmesallamy W, Waley AB, Obaya AA, Gharieb SA, Amgd K, Ibrahim SM, Abdelhamid MI, Khamis T, Mohamed AH.   +12 more
europepmc   +1 more source

IDH2 (isocitrate dehydrogenase 2 (NADP+), mitochondrial)

, 2018
Jean Loup Huret, Philippe Dessen
openalex   +1 more source

Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. [PDF]

Neuro Oncol
Gupta P, Dang M, Oberai S, Migliozzi S, Trivedi R, Kumar G, Peshoff M, Milam N, Ahmed A, Bojja K, Tran TM, Gumin J, Kamiya-Matsuoka C, Huse J, Cox K, Li J, Shehwana H, Sheth SA, Saxon R, Baohua S, Parker Kerrigan B, Maheshwari A, Parra Cuentas ER, Navin NE, Heimberger AB, Lang FF, Iavarone A, Clise-Dwyer K, Wang L, Bhat KP.   +29 more
europepmc   +1 more source

Studies on the Mechanism of Action of Isocitric Dehydrogenase

Journal of Biological Chemistry, 1960
openaire   +2 more sources

A scoping review of proton radiation therapy and mutant-isocitrate dehydrogenase-inhibitors in IDH mutated lower-grade gliomas: pushing beyond surrogate end-points. [PDF]

Acta Neurochir (Wien)
Harba D, Corell A, Mansouri A, Brandal P, Blomstrand M, Jakola AS.   +5 more
europepmc   +1 more source

Clinical Implications of Isocitrate Dehydrogenase Mutations and Targeted Treatment of Acute Myeloid Leukemia with Mutant Isocitrate Dehydrogenase Inhibitors-Recent Advances, Challenges and Future Prospects. [PDF]

Int J Mol Sci
Kowalczyk A, Zarychta J, Lejman M, Latoch E, Zawitkowska J.   +4 more
europepmc   +1 more source

Comprehensive multicentre retrospective analysis for predicting isocitrate dehydrogenase-mutant lower-grade gliomas. [PDF]

Ann Clin Transl Neurol
Zhao D, Duan L, Juratli TA, Shen F, Zhou L, Cui S, Zhang H, Ren H, Cheng L, Wang H, Shi W, Li T, Li M.   +12 more
europepmc   +1 more source

Isocitrate Dehydrogenase-Wildtype Glioma Adapts Toward Mutant Phenotypes and Enhanced Therapy Sensitivity Under D-2-Hydroxyglutarate Exposure. [PDF]

Biomedicines
Rocha G, Francés-Gómez C, Megías J, Muñoz-Hidalgo L, Casanova P, Haro-Estevez JF, Teruel-Martí V, Monleón D, San-Miguel T.   +8 more
europepmc   +1 more source